Prospective WCD Post CABG Registry (CABG Registry)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZoll Medical Corporation
About this trial
The primary objective is to observe the rate of recovery of ventricular function (EF\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.
Eligibility criteria
Qualifiers
Patient underwent first-time CABG surgery <10 days before enrollment.
Patient is prescribed WCD for a primary reason of HF with reduced EF < 35% measured after surgery but before hospital discharge.
Patient is ≥18 years old
Disqualifiers
Patients having combination CABG surgery with heart valve repair.
Patients with prior CABG.
Patients who have an active unipolar pacemaker.
Patients with a physical or mental condition that could impair their ability to properly interact with the WCD.
Trial design
Treatments tested in this trial
- WCD
Treatment groups
No treatment groups listed
Locations
4Kerckhoff Klinik61231, Bad NauheimHesse, Germany
Medizinische Hochschule Hannover30625, HanoverLower Saxony, Germany
Sana-Herzzentrum Cottbus GmbH03048, Cottbus Germany
Universitätsklinikum Halle (Saale)06120, Halle Germany
Sponsors and collaborators
Zoll Medical Corporation
Lead sponsor
Source ClinicalTrials.gov